| Molecular understanding and modern application of traditional medicines: triumphs and trials TW Corson, CM Crews Cell 130 (5), 769-774, 2007 | 716 | 2007 |
| Retinoblastoma H Dimaras, TW Corson, D Cobrinik, A White, J Zhao, FL Munier, ... Nature reviews Disease primers 1 (1), 1-23, 2015 | 582 | 2015 |
| Using expression profiling data to identify human microRNA targets JC Huang, T Babak, TW Corson, G Chua, S Khan, BL Gallie, TR Hughes, ... Nature methods 4 (12), 1045-1049, 2007 | 475 | 2007 |
| Small-molecule hydrophobic tagging–induced degradation of HaloTag fusion proteins TK Neklesa, HS Tae, AR Schneekloth, MJ Stulberg, TW Corson, ... Nature chemical biology 7 (8), 538-543, 2011 | 437 | 2011 |
| Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies DE Rushlow, BM Mol, JY Kennett, S Yee, S Pajovic, BL Thériault, ... The lancet oncology 14 (4), 327-334, 2013 | 421 | 2013 |
| Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma H Dimaras, V Khetan, W Halliday, M Orlic, NL Prigoda, B Piovesan, ... Human molecular genetics 17 (10), 1363-1372, 2008 | 344 | 2008 |
| One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma TW Corson, BL Gallie Genes, Chromosomes and Cancer 46 (7), 617-634, 2007 | 314 | 2007 |
| Global retinoblastoma presentation and analysis by national income level ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, SA Boubacar, ... JAMA oncology 6 (5), 685-695, 2020 | 301 | 2020 |
| Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs J Hines, JD Gough, TW Corson, CM Crews Proceedings of the National Academy of Sciences 110 (22), 8942-8947, 2013 | 227 | 2013 |
| Design and applications of bifunctional small molecules: why two heads are better than one TW Corson, N Aberle, CM Crews ACS chemical biology 3 (11), 677-692, 2008 | 215 | 2008 |
| The genomic landscape of retinoblastoma: a review BL Thériault, H Dimaras, BL Gallie, TW Corson Clinical & experimental ophthalmology 42 (1), 33-52, 2014 | 213 | 2014 |
| Retinoblastoma, the visible CNS tumor: a review H Dimaras, TW Corson Journal of neuroscience research 97 (1), 29-44, 2019 | 199 | 2019 |
| KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers TW Corson, A Huang, MS Tsao, BL Gallie Oncogene 24 (30), 4741-4753, 2005 | 193 | 2005 |
| Small-molecule covalent modification of conserved cysteine leads to allosteric inhibition of the TEAD⋅ Yap protein-protein interaction K Bum-Erdene, D Zhou, G Gonzalez-Gutierrez, MK Ghozayel, Y Si, D Xu, ... Cell chemical biology 26 (3), 378-389. e13, 2019 | 158 | 2019 |
| Primary cilia signaling mediates intraocular pressure sensation N Luo, MD Conwell, X Chen, CI Kettenhofen, CJ Westlake, LB Cantor, ... Proceedings of the National Academy of Sciences 111 (35), 12871-12876, 2014 | 137 | 2014 |
| KIF14 mRNA expression is a predictor of grade and outcome in breast cancer TW Corson, BL Gallie International journal of cancer 119 (5), 1088-1094, 2006 | 128 | 2006 |
| Profiling genomic copy number changes in retinoblastoma beyond loss of RB1 E Bowles, TW Corson, J Bayani, JA Squire, N Wong, PBS Lai, BL Gallie Genes, Chromosomes and Cancer 46 (2), 118-129, 2007 | 126 | 2007 |
| KIF14 Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer TW Corson, CQ Zhu, SK Lau, FA Shepherd, MS Tsao, BL Gallie Clinical Cancer Research 13 (11), 3229-3234, 2007 | 125 | 2007 |
| Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization HD Basavarajappa, B Lee, H Lee, RS Sulaiman, H An, C Magaña, ... Journal of Medicinal Chemistry 58 (12), 5015-5027, 2015 | 103* | 2015 |
| Natural product inhibitors of ocular angiogenesis RS Sulaiman, HD Basavarajappa, TW Corson Experimental eye research 129, 161-171, 2014 | 99 | 2014 |
